MARX Biotech Co., Ltd.(TW:7731)
NT$4.26-0.09 (-2.07%)
TW:7731
MARX Biotech Co., Ltd. financials statements
NT$4.26
At close:-0.09 (-2.07%)
MARX Biotech Co., Ltd. (7731) Financial Statements
MARX Biotech Co., Ltd. Financial Overview
MARX Biotech Co., Ltd.'s market cap is currently NT$2.35B. The company's EPS TTM is NT$0.10; its P/E ratio is 42.61; and it has a dividend yield of 1.34%. MARX Biotech Co., Ltd. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | NT$ 635.85M | NT$ 618.23M | NT$ 289.93M | NT$ 110.64M | NT$ 97.61M |
| Gross Profit | NT$ 394.59M | NT$ 430.07M | NT$ 214.59M | NT$ 84.21M | NT$ 74.79M |
| Operating Income | NT$ -139.46M | NT$ -77.39M | NT$ -14.34M | NT$ 898.00K | NT$ 15.05M |
| EBITDA | NT$ 91.00M | NT$ -77.25M | NT$ -10.52M | NT$ 6.97M | NT$ 19.01M |
| Net Income | NT$ 42.92M | NT$ -96.83M | NT$ -12.92M | NT$ 2.83M | NT$ 13.78M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | NT$ 34.77M | NT$ 78.17M | NT$ 152.83M | NT$ 27.73M | NT$ 16.13M |
| Total Assets | NT$ 832.72M | NT$ 731.20M | NT$ 394.85M | NT$ 103.19M | NT$ 91.08M |
| Total Debt | NT$ 307.76M | NT$ 277.42M | NT$ 1.88M | NT$ 13.84M | NT$ 2.10M |
| Net Debt | NT$ 274.99M | NT$ 202.75M | NT$ -150.94M | NT$ -13.89M | NT$ -14.03M |
| Total Liabilities | NT$ 473.34M | NT$ 479.95M | NT$ 101.86M | NT$ 42.45M | NT$ 25.46M |
| Stockholders' Equity | NT$ 359.38M | NT$ 251.25M | NT$ 292.99M | NT$ 60.73M | NT$ 65.61M |
| Cash Flow | |||||
| Free Cash Flow | NT$ -162.84M | NT$ -325.74M | NT$ -15.88M | NT$ 10.74M | NT$ -16.75M |
| Operating Cash Flow | NT$ -148.73M | NT$ -107.18M | NT$ -14.14M | NT$ 11.44M | NT$ -16.71M |
| Investing Cash Flow | NT$ -81.59M | NT$ -286.48M | NT$ -78.09M | NT$ -793.00K | NT$ -48.00K |
| Financing Cash Flow | NT$ 188.42M | NT$ 315.50M | NT$ 217.33M | NT$ 953.00K | NT$ 29.49M |
Currency in TWD

